Press Room

WASHINGTON, DC – APRIL 16, 2026 – The American Cancer Society Cancer Action Network (ACS CAN) released a new report today showing the scope of cancer disparities in the United States and recommended local, state and federal policies that can help reduce them. Cancer Disparities: An American Cancer Society Cancer Action Network Chartbook examines disparities in cancer screening, prevention and early detection, disparities in cancer incidence, mortality and survival, as well as disparities in access to health coverage.

As the administration releases its proposed budget for Fiscal Year 2027, the American Cancer Society Cancer Action Network (ACS CAN) is calling on Congress to maintain its longstanding bipartisan commitment to robust, increased investments in cancer research and prevention.  

The American Cancer Society Cancer Action Network (ACS CAN) announces two new members alongside newly-elected leadership officers to the Board of Directors for 2026.

As new federal data show continued declines in youth tobacco use, the American Cancer Society Cancer Action Network (ACS CAN) is urging the U.S. Food and Drug Administration (FDA) to reject any effort to authorize new flavored tobacco products, including coffee, mint and cinnamon. Flavors have long been used by Big Tobacco to appeal to and addict young people to their deadly products.

This week, the American Cancer Society Cancer Action Network submitted comments in a letter opposing several policies in the Patient Protection and Affordable Care Act HHS Notice of Benefit and Payment Parameters  proposed rule for plan year 2027.

The American Cancer Society Cancer Action Network (ACS CAN) released today results from a survey exploring cancer patients and survivors’ attitudes toward vaccines.

Today, the American Cancer Society Cancer Action Network (ACS CAN) was joined by 24 other organizations in proposing the Health and Human Services Office of Inspector General adopt a new regulatory safe harbor from the Anti-kickback Statute that would allow clinical trial sponsors to financially support patients to offset indirect or non-medical costs associated with clinical trial participation, such as travel, parking and lodging.

Washington, D.C. - Today, the Trump Administration released the list of 15 drugs for the next round of Medicare price negotiation, including four drugs to treat cancer: Erleada to treat prostate cancer, Kisqa

Today, the Congressional Appropriations Committees released the FY2026 Labor, Health and Human Services, Education and Related Agencies appropriations bill that reaffirms the bipartisan commitment to advancing cancer research and saving lives by continued and increased funding for the National Institutes of Health (NIH) and the National Cancer Institute (NCI).

Following today’s bipartisan House vote on extending the enhanced tax credits, ACS CAN is once again calling on members of the Senate and the House to prioritize the health and wellbeing of their constituents and come together in a bipartisan, bicameral way to extend the enhanced premium tax credits immediately.